Cytology positive pleural aspirations: sufficient to guide treatment?

R. Varatharajah (Oxford, United Kingdom), G. Shepherd (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), A. Thanayanandan (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)

Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Session: Novel approaches to pleural effusion: should I change my practice?
Session type: Oral Presentation
Number: 490
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Varatharajah (Oxford, United Kingdom), G. Shepherd (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), A. Thanayanandan (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). Cytology positive pleural aspirations: sufficient to guide treatment?. 490

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this?
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019

In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment?
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

Ultrasound guided pleural brushing: A new method for obtaining pleural specimen in malignant effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Diagnosis of malignant pleural effusions; cytology or biopsy?
Source: Eur Respir J 2004; 24: Suppl. 48, 72s
Year: 2004

Diagnostic yield of pleural fluid cytology in malignant effusions – Is timing of collection important?
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Utility of ultrasound-guided pleural biopsy in guiding treatment for malignant pleural disease
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Pleural fluid ‘cell block’ analysis in malignant pleural effusion: sensitive, superior over fluid cytology and suitable for immunohistochemistry analysis (IHC), will decrease need for thoracoscopy guided procedures
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


An audit of the use of Abrams‘ pleural biopsy in the diagnosis of mesothelioma
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Smear cytology of Pleural nodule during Thoracoscopy - A new approach for early diagnosis of Pleural pathology.
Source: International Congress 2018 – Pleural interventions
Year: 2018


Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 50s
Year: 2006

Closed percutaneous pleural brushing: a novel diagnostic approach for diagnosis of malignant pleural effusions
Source: Eur Respir J 2007; 30: Suppl. 51, 102s
Year: 2007

Bronchoscopy and endobronchial biopsies in children: Useful or not?
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012



Blind pleural biopsy: it still remains available nowadays?
Source: ERS Skills Course 2017 - Thoracoscopy and Pleural Techniques
Year: 2017

Medical thoracoscopy- Comparison of pleural biopsy, imprint cytology and cytology of pleural effusion
Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions
Year: 2019


Diagnostic yield of cytology in malignant pleural effusion: Impact of volume and repeated thoracentesis
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Does blind percutaneous pleural biopsy have a role in the investigation of pleural effusion? A pooled analysis
Source: Annual Congress 2009 - Pleural diseases
Year: 2009


Prospective randomised trial of 'blind' Abram's pleural biopsies versus CT guided cutting needle biopsies in cytology negative undiagnosed pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 605s
Year: 2002

Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019